Clinical Trials Browser

Phase 2 × Lymphoma, T-Cell × Magnetic Resonance Spectroscopy × Clear all

NCT07293403 2026-06-02

Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas

Phase 2 Recruiting

Lymphoma, T-Cell